Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer.
- Published In:
- Cancers, 16(24) (2024)
- Authors:
- Morisaki, Takafumi, Kubo, Makoto, Morisaki, Shinji, Umebayashi, Masayo, Tanaka, Hiroto, Koya, Norihiro, Nakagawa, Shinichiro, Tsujimura, Kenta, Yoshimura, Sachiko, Kiyotani, Kazuma, Nakamura, Yusuke, Nakamura, Masafumi, Morisaki, Takashi
- Database ID:
- RPEP-08900
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-08900APA
Morisaki, Takafumi; Kubo, Makoto; Morisaki, Shinji; Umebayashi, Masayo; Tanaka, Hiroto; Koya, Norihiro; Nakagawa, Shinichiro; Tsujimura, Kenta; Yoshimura, Sachiko; Kiyotani, Kazuma; Nakamura, Yusuke; Nakamura, Masafumi; Morisaki, Takashi. (2024). Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer.. Cancers, 16(24). https://doi.org/10.3390/cancers16244204
MLA
Morisaki, Takafumi, et al. "Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer.." Cancers, 2024. https://doi.org/10.3390/cancers16244204
RethinkPeptides
RethinkPeptides Research Database. "Retrospective Analysis of HLA Class II-Restricted Neoantigen..." RPEP-08900. Retrieved from https://rethinkpeptides.com/research/morisaki-2024-retrospective-analysis-of-hla
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.